Tonix Pharmaceuticals Holding Corp at Noble Capital Markets Investor Conference (Virtual) Transcript
Good morning. My name is Seth Lederman. I'm the CEO of Tonix Pharmaceuticals, and I'm grateful to you for coming to see the presentation. I'm grateful to the organizers for having us speak. Today, I've got a lot to say. I'm going to try to fit it into the time we have.
We have some exciting new analyses that have never been presented before about Long COVID, which is one of our programs. And I'm going to talk about the relationship of Long COVID to fibromyalgia, which is another condition which Tonix has a program in.
But first, let me take a breath and say Tonix is a public company. We're traded on NASDAQ under the ticker TNXP, and I will be making forward-looking statements, and I refer you to our SEC documents for more complete information about the company.
One of the most distinctive things about Tonix is the broad portfolio of products that we have in development. So we have an engine of discovery, manufacturing, regulatory, clinical development, and other things. And that's why it's been efficient
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
